US growth delivers £13m turnover for Knutsford-based Crawford Healthcare
Wound care and dermatology firm Crawford Healthcare is celebrating after growing its half-year revenues by more than £2m.
The Knutsford-based business’ turnover leapt to £13m during the six months to September 30, a year-on-year rise of 19%.
Crawford Healthcare has attributed the growth to both its performance in the UK and overseas, in particular the US, where revenues from its North American subsidiary rose by 136% during the period.
The CEO of Crawford Healthcare, Richard Anderson, said: “As anticipated, we’ve enjoyed a really strong first six months for 2016/17, and we are well set to exceed expectations for the full year.
“The success of our wound care brands – now entirely owned and developed by Crawford – goes to show the quality of the Life Sciences industry in Cheshire and the North West.”
He added: “Like many others in the region, we’re enjoying tremendous success overseas and showing how our IP can lead international thinking and practice in healthcare.”
Crawford has achieved average annual sales growth of 41% over the last three years and today employs more than 130 people across its UK and international teams.
In July, a report found that one product developed by Crawford Healthcare alongside the University of Manchester could save the NHS as much as £125m a year.
Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →
Creating a thriving North East construction sector
Why investors are still backing the North East
Time to stop risking Britain’s family businesses
A year of growth, collaboration and impact
2000 reasons for North East business positivity
How to make your growth strategy deliver in 2026
Powering a new wave of regional screen indies
A new year and a new outlook for property scene
Zero per cent - but maximum brand exposure
We don’t talk about money stress enough
A year of resilience, growth and collaboration
Apprenticeships: Lower standards risk safety